Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alliant Energy Corporation (LNT) vs TransMedics Group Inc (TMDX) Price & Performance

Alliant Energy CorporationTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Alliant Energy Corporation vs TransMedics Group Inc — how do they compare? Alliant Energy Corporation trades at $72.45 (market cap $19.10B), while TransMedics Group Inc trades at $74.7 (market cap $2.54B). The key difference: Alliant Energy Corporation is far larger — about 7.5× TransMedics Group Inc's market cap, and Alliant Energy Corporation pays a 2.89% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

LNTTMDX
Market Cap
$19.10B$2.54B
Sector
UtilitiesTechnology
52-Week High
$78.03$150.42
52-Week Low
$63.62$61.99
Enterprise Value
$30.83B$2.94B
Dividend Yield
2.89%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alliant Energy Corporation

LNT trades at $73.96, down 1.16% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $78.50. The company reported Q1 2026 EPS of $0.82, beating expectations, and maintains a net income margin of 18.58%. Recent news highlights its $13.4 billion clean energy investment plan aimed at capitalizing on data center demand growth.

The outlook for LNT is positive, supported by steady earnings growth, a strong dividend yield, and strategic investments in renewable energy. Key risks include rising debt levels and exposure to regulatory changes in the utilities sector. Analyst sentiment is bullish with no sell ratings, indicating confidence in the company's long-term growth trajectory.

TransMedics Group Inc

TransMedics (TMDX) trades at $73.47, down 0.69% with neutral technical signals. The stock shows strong profitability with 27% net margins and 45% ROE, though Q1 2026 earnings missed expectations. Recent strategic investment in European aviation logistics aims to expand the Organ Care System platform. Analyst consensus remains bullish with a $108.71 price target representing 48% upside potential.

Long-term growth prospects appear solid given TMDX's expanding transplant ecosystem, but near-term margin pressure from expansion investments and execution risks warrant caution. The company maintains competitive advantages in organ transplant logistics, though increased spending and competitive threats from alternatives like Strata Critical Medical present headwinds for shareholder returns.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Alliant Energy Corporation

Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.

Read more on LNT

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX